A recent study confirms that a single-lead artificial intelligence (AI)-enabled electrocardiogram (ECG) serves as a powerful ...
L1, EBV and mismatch repair deficiency suggests CLDN18.2 stratification must be integrated into multi-biomarker algorithms ...
Morning Overview on MSN
Study identifies biomarker that may aid Parkinson’s and Lewy body diagnosis
Researchers have developed an infrared-based sensor that detects misfolded alpha-synuclein protein in spinal fluid with ...
As the global burden of obesity, type 2 diabetes, and metabolic syndrome continues to rise, fatty liver disease has become ...
As the global burden of obesity, type 2 diabetes, and metabolic syndrome continues to rise, fatty liver disease has become one of the most prevalent ...
Germany: Researchers have discovered in a new study that among patients with chronic subdural hematoma undergoing burr hole ...
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received CE Mark approval for its Elecsys® Apolipoprotein E4 ...
(NYSE: PFE) today announced positive topline results from the Phase 3 TALAPRO-3 study of TALZENNA ® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI ® ...
Morning Overview on MSN
Electrical stimulation helps restore movement and sensation after spinal injury
Researchers at Brown University have demonstrated that targeted electrical stimulation of the spinal cord can restore both ...
Background Endovascular therapy (EVT) is standard treatment for large vessel occlusion in patients with a National Institutes ...
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results